UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 15, 2011
ProUroCare Medical Inc.
(Exact Name of Registrant as Specified in its Charter)
|
Nevada
|
000-51774
|
20-1212923
|
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota 55344
|
||
|
(Address of Principal Executive Offices) (Zip Code)
|
||
|
(952) 476-9093
|
||
|
(Registrant’s Telephone Number, Including Area Code)
|
||
|
Not Applicable
|
||
|
(Former Name or Former Address, if Changed Since Last Report)
|
||
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
||
Item 1.01 Entry into Material Definitive Agreements
Amendment to Promissory Note
On April 15, 2011, ProUroCare Medical Inc. (the “Company”) amended its $900,000 promissory note with Crown Bank. The amendment provides an extension of the maturity date of the note from March 28, 2011 to September 28, 2011, with no other changes in the note terms. The notes remain secured by all Company assets and are guaranteed by James L. Davis, a director of the Company, and William S. Reiling.
Item 2.03 Creation of a Direct financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Company
See “Amendment to Promissory Note” in Item 1.01 above.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
PROUROCARE MEDICAL INC.
|
||
|
April 21, 2011
|
By:
|
/s/ Rick Carlson
Richard C. Carlson
Chief Executive Officer
|